Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity

Abstract Amyotrophic Lateral Sclerosis (ALS) is a lethal neurodegenerative disorder that primarily affects motor neurons. Dominant mutations in the RNA binding protein Fused in Sarcoma (FUS) have been identified as causative factors of ALS. Mutation, R495X, results in a premature stop codon and indu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tadashi Nakaya, Manolis Maragkakis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cb8569e4b09147fbb1c3b6d12bdc69e5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb8569e4b09147fbb1c3b6d12bdc69e5
record_format dspace
spelling oai:doaj.org-article:cb8569e4b09147fbb1c3b6d12bdc69e52021-12-02T15:08:53ZAmyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity10.1038/s41598-018-33964-02045-2322https://doaj.org/article/cb8569e4b09147fbb1c3b6d12bdc69e52018-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-33964-0https://doaj.org/toc/2045-2322Abstract Amyotrophic Lateral Sclerosis (ALS) is a lethal neurodegenerative disorder that primarily affects motor neurons. Dominant mutations in the RNA binding protein Fused in Sarcoma (FUS) have been identified as causative factors of ALS. Mutation, R495X, results in a premature stop codon and induces an aggressive disease phenotype by a largely unknown process. Here, we employ CLIP-Seq, RNA-Seq and Ribo-Seq in cultured neurons expressing R495X or wild-type FUS to identify the mutation effects on the FUS targetome and on the neuronal transcriptome at the expression and translation level, simultaneously. We report that, unlike wild-type FUS that binds on precursor mRNAs (pre-mRNAs), R495X binds mature mRNAs in the cytoplasm. R495X has a moderate effect on target mRNA expression and its binding induces only modest expression changes. In contrast, we find that R495X controls the translation of genes that are associated with mitochondria function and results in significant reduction of mitochondrial size. Importantly, we show that introduction of the 4FL mutation that alters binding of R495X to RNA, partially abrogates R495X-induced effects on mRNA translation, mitochondrial size and neurotoxicity. Our findings uncover a novel RNA-mediated pathway of FUS R495X-induced neurotoxicity that affects mitochondria morphology and provide insight to previous studies associating mitochondria dysfunction to ALS.Tadashi NakayaManolis MaragkakisNature PortfolioarticleMitochondria ShorteningRX821002 BindingAggressive Disease PhenotypeTargetomeMitochondria SizeMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Mitochondria Shortening
RX821002 Binding
Aggressive Disease Phenotype
Targetome
Mitochondria Size
Medicine
R
Science
Q
spellingShingle Mitochondria Shortening
RX821002 Binding
Aggressive Disease Phenotype
Targetome
Mitochondria Size
Medicine
R
Science
Q
Tadashi Nakaya
Manolis Maragkakis
Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
description Abstract Amyotrophic Lateral Sclerosis (ALS) is a lethal neurodegenerative disorder that primarily affects motor neurons. Dominant mutations in the RNA binding protein Fused in Sarcoma (FUS) have been identified as causative factors of ALS. Mutation, R495X, results in a premature stop codon and induces an aggressive disease phenotype by a largely unknown process. Here, we employ CLIP-Seq, RNA-Seq and Ribo-Seq in cultured neurons expressing R495X or wild-type FUS to identify the mutation effects on the FUS targetome and on the neuronal transcriptome at the expression and translation level, simultaneously. We report that, unlike wild-type FUS that binds on precursor mRNAs (pre-mRNAs), R495X binds mature mRNAs in the cytoplasm. R495X has a moderate effect on target mRNA expression and its binding induces only modest expression changes. In contrast, we find that R495X controls the translation of genes that are associated with mitochondria function and results in significant reduction of mitochondrial size. Importantly, we show that introduction of the 4FL mutation that alters binding of R495X to RNA, partially abrogates R495X-induced effects on mRNA translation, mitochondrial size and neurotoxicity. Our findings uncover a novel RNA-mediated pathway of FUS R495X-induced neurotoxicity that affects mitochondria morphology and provide insight to previous studies associating mitochondria dysfunction to ALS.
format article
author Tadashi Nakaya
Manolis Maragkakis
author_facet Tadashi Nakaya
Manolis Maragkakis
author_sort Tadashi Nakaya
title Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
title_short Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
title_full Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
title_fullStr Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
title_full_unstemmed Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
title_sort amyotrophic lateral sclerosis associated fus mutation shortens mitochondria and induces neurotoxicity
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/cb8569e4b09147fbb1c3b6d12bdc69e5
work_keys_str_mv AT tadashinakaya amyotrophiclateralsclerosisassociatedfusmutationshortensmitochondriaandinducesneurotoxicity
AT manolismaragkakis amyotrophiclateralsclerosisassociatedfusmutationshortensmitochondriaandinducesneurotoxicity
_version_ 1718388027790721024